Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

High-throughput discovery and characterization of viral transcriptional effectors in human cells

ABSTRACT: High-throughput discovery and characterization of viral transcriptional effectors in human cells

PROVIDER: PRJNA930640 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23316233_1.fastq.gz	Fastqsanger.gz
	SRR23316233_2.fastq.gz	Fastqsanger.gz
	SRR23316234_1.fastq.gz	Fastqsanger.gz
	SRR23316234_2.fastq.gz	Fastqsanger.gz
	SRR23316235_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 196

Similar Datasets

High-throughput discovery and characterization of viral transcriptional effectors in human cells

Project description:Viruses encode transcriptional regulatory proteins critical for controlling viral and host gene expression. Given their multifunctional nature and high sequence divergence, it is unclear which viral proteins can affect transcription and which specific sequences contribute to this function. Using a high-throughput assay, we measured the transcriptional regulatory potential of over 60,000 protein tiles across ~1,500 proteins from 11 coronaviruses and all nine human herpesviruses. We discovered hundreds of new transcriptional effector domains, including a conserved repression domain in all coronavirus Spike homologs, dual activation-repression domains in VIRFs, and an activation domain in six herpesvirus homologs of the single-stranded DNA-binding protein that we show is important for viral replication and late gene expression in KSHV. For the effector domains we identified, we investigated their mechanisms via high-throughput sequence and chemical perturbations, pinpointing sequence motifs essential for function. This work massively expands viral protein annotations, serving as a springboard for studying their biological and health implications and providing new candidates for compact gene regulation tools.

2023-02-03 | GSE224325 | GEO

High-Throughput Discovery and Characterization of Human Transcriptional Effectors.

Project description:Thousands of proteins localize to the nucleus; however, it remains unclear which contain transcriptional effectors. Here, we develop HT-recruit, a pooled assay where protein libraries are recruited to a reporter, and their transcriptional effects are measured by sequencing. Using this approach, we measure gene silencing and activation for thousands of domains. We find a relationship between repressor function and evolutionary age for the KRAB domains, discover that Homeodomain repressor strength is collinear with Hox genetic organization, and identify activities for several domains of unknown function. Deep mutational scanning of the CRISPRi KRAB maps the co-repressor binding surface and identifies substitutions that improve stability/silencing. By tiling 238 proteins, we find repressors as short as ten amino acids. Finally, we report new activator domains, including a divergent KRAB. These results provide a resource of 600 human proteins containing effectors and demonstrate a scalable strategy for assigning functions to protein domains.

| S-EPMC8178797 | biostudies-literature

High-throughput discovery of post-transcriptional cis-regulatory elements

Project description:High-throughput discovery of post-transcriptional cis-regulatory elements

| PRJNA302654 | ENA

High-throughput Discovery of Functional Protein Modifications by Hotspot Thermal Profiling

Project description:High-throughput Discovery of Functional Protein Modifications by Hotspot Thermal Profiling

2019-05-16 | MSV000083786 | MassIVE

High-throughput discovery of human antimicrobial peptide activators of Salmonella Typhimurium PhoPQ

Project description:High-throughput discovery of human antimicrobial peptide activators of Salmonella Typhimurium PhoPQ

| PRJNA728703 | ENA

High-Throughput 5’ UTR Engineering for Enhanced Protein Production in Non-Viral Gene Therapies

Project description:Here, we develop a high-throughput strategy to design, screen, and optimize 5’ UTRs that enhance protein expression from a strong human cytomegalovirus (CMV) promoter. We first identify naturally occurring 5’ UTRs with high translation efficiencies and use this information with in silico genetic algorithms to generate synthetic 5’ UTRs. A total of ~12,000 5’ UTRs are then screened using a recombinase-mediated integration strategy that greatly enhances the sensitivity of high-throughput screens by eliminating copy number and position effects that limit lentiviral approaches. Using this approach, we identify three synthetic 5’ UTRs that outperform commonly used non-viral gene therapy plasmids in expressing protein payloads.

2021-06-11 | GSE176581 | GEO

A high-throughput mass spectrometric assay for discovery of human lipoxygenase inhibitors and allosteric effectors.

Project description:Lipoxygenases (LOXs) regulate inflammation through the production of a variety of molecules whose specific downstream effects are not entirely understood due to the complexity of the inflammation pathway. The generation of these biomolecules can potentially be inhibited and/or allosterically regulated by small synthetic molecules. The current work describes the first mass spectrometric high-throughput method for identifying small molecule LOX inhibitors and LOX allosteric effectors that change the substrate preference of human lipoxygenase enzymes. Using a volatile buffer and an acid-labile detergent, enzymatic products can be directly detected using high-performance liquid chromatography-mass spectrometry (HPLC-MS) without the need for organic extraction. The method also reduces the required enzyme concentration compared with traditional ultraviolet (UV) absorbance methods by approximately 30-fold, allowing accurate binding affinity measurements for inhibitors with nanomolar affinity. The procedure was validated using known LOX inhibitors and the allosteric effector 13(S)-hydroxy-9Z,11E-octadecadienoic acid (13-HODE).

| S-EPMC4398643 | biostudies-literature

High-throughput drug target discovery by fully automated proteomics sample preparation platform

Project description:Drug development is plagued by inefficiency and high costs due to issues such as inadequate drug efficacy and unexpected toxicity. Mass spectrometry (MS)-based proteomics, particularly isobaric quantitative proteomics, offers a solution to unveil resistance mechanisms and unforeseen side effects related to off-targeting pathways. Thermal proteome profiling (TPP) has gained popularity for drug target identification at the proteome scale. However, it involves experiments with multiple temperature points, resulting in numerous samples and considerable variability in large-scale TPP analysis. We propose a high-throughput drug target discovery workflow that integrates single-temperature TPP, a fully automated proteomics sample preparation platform (autoSISPROT), and Data Independent Acquisition (DIA) quantification. The autoSISPROT platform enables the simultaneous processing of 96 samples in less than 2.5 hours, achieving protein digestion, desalting, and optional TMT labeling (requires an additional 1 hour) with 96-channel all-in-tip operations. The results demonstrated excellent sample preparation performance with >94% digestion efficiency, >98% TMT labeling efficiency, and >0.9 of intraand inter-batch Pearson correlation coefficients. By automatically processing 87 samples, we identified both known targets and potential off-targets of 20 kinase inhibitors, affording over a 10-fold improvement in throughput compared to classical TPP. This fully automated workflow offers a high-throughput solution for proteomics sample preparation and drug target/off-target identification.

2024-01-16 | PXD044006 | Pride

Small non-coding RNA discovery and profiling with sRNAtools based on high-throughput sequencing

Project description:Small non-coding RNA discovery and profiling with sRNAtools based on high-throughput sequencing

| PRJNA587495 | ENA

Autologous antibody capture to enrich immunogenic viruses for viral discovery

Project description:Autologous antibody capture to enrich immunogenic viruses for viral discovery

| PRJEB4561 | ENA